SAN DIEGO--(BUSINESS WIRE)--Paracrine, Inc., announced today the online publication (ahead of print) of the findings from the STAR I trial in Arthritis & Rheumatology Journal, the official journal of ...

Forty-six patients with scleroderma (3 male and 43 female) and 31 healthy controls (6 male and 25 female) were included in the study. Twenty-five patients had limited-type and 21 patients had ...

Scleroderma is a rare disease, yet its initial symptoms are frequently encountered in general rheumatology practice as features of the more-common rheumatic diseases and of several 'scleroderma-like' ...

Daval International today announced positive results from its Double-Blind Placebo-Controlled Phase II Clinical Study evaluating the safety and tolerability of AIMSPRO given as a monotherapy to ...

(HealthDay News) – Patients with diffuse systemic sclerosis (SSc), without any clinical evidence of cardiovascular disease, have indicators of subclinical atherosclerosis. To identify signs of early ...

Localized scleroderma, as the term denotes, is localized to the skin on the hands and face. It is characterized by slow progression and rarely transforms to the systemic type. Localized scleroderma is ...

Department of Rheumatology, Noble’s Hospital, Douglas, Isle of Man.. A 73 years old female with known history of diffuse systemic scleroderma with pulmonary and renal involvement, presented with dizzy ...

1 Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 2 Department of Dermatology, Minhang Hospital, Fudan University, Shanghai, ...

Scleroderma is a rare and complex autoimmune disease that leads to the tightening and hardening of the skin and connective tissues. This condition, also known as systemic sclerosis, results from the ...

Background Juvenile systemic sclerosis (jSSc) is an orphan disease with a prevalence of 3 in 1 000 000 children (1). In adult patients there are significant differences between the clinical ...